BPC-157
Body-repair peptide derived from human gastric protective proteins.
About BPC-157
BPC-157 (Body Protection Compound-157) is a synthetic peptide derived from a protective protein found in human gastric juice. It has shown remarkable regenerative properties across multiple tissues: muscle, tendon, ligament, bone and the nervous system. It works by promoting angiogenesis (the formation of new blood vessels), modulating nitric-oxide production and protecting the vascular endothelium.
How it works
- 1Mechanism: promotes angiogenesis and modulates nitric oxide, accelerating the repair of soft tissue.
- 2Typical protocol: subcutaneous injection near the injury site, one to two times a day.
- 3Expected timeline: improvements in inflammation by around 2 weeks; noticeable tissue repair between weeks 4 and 8.
- 4Follow-up: clinical review at 4 weeks to adjust the protocol or extend the cycle.
Suggested protocol: 4–12 week cycle depending on the condition, with reassessment at 4 weeks.
Benefits
- Accelerated repair of tendons and ligaments
- Healing of gastric and intestinal ulcers
- Protection of the nervous system and brain
- Reduction of systemic inflammation
- Improved wound healing
- Protection against liver damage
Safety and compliance
Protocol supervised by Dr. Xavier Guzmán
Professional license (cédula) 15115581, verifiable with SEP
- COFEPRIS-regulated clinic. Peptides prepared in licensed compounding pharmacies.
- Investigational / clinical use under medical prescription. Not FDA-approved as an over-the-counter treatment.
- Widely studied in preclinical models with a favorable safety profile
- Published studies show a favorable tolerability profile
- Requires medical supervision for correct dosing
Contraindications
- Pregnancy and breastfeeding
- Active cancer or recent history of cancer
- Under 18 years of age
Frequently asked questions about BPC-157
Answers specific to this peptide. For questions about the program in general, visit our general FAQ.
Yes. BPC-157 is especially useful for chronic tendinopathies, ligament injuries and musculoskeletal pain that has not responded to physical therapy. The physician determines whether it is the right protocol for your case.
Yes. A subcutaneous injection near the injured area is often part of the protocol, but the exact technique is determined by your physician based on the region and the type of tissue involved.
Patients report improvements in inflammation and pain within the first 2 weeks. Deeper tissue repair usually consolidates between weeks 4 and 8.
Yes. BPC-157 is frequently combined with TB-500 in regeneration protocols. Your physician decides the optimal synergy for your goals.
Published studies show a favorable tolerability profile. Some patients notice mild, transient redness at the injection site.
Price
Ask at consultation
Personalized quote after medical evaluation
1 month
start
Ask at consultation
3 months
Ask at consultation
6 months
Ask at consultation
Administration
Subcutaneous injection or oral application
Duration
4–12 weeks depending on the condition
Prior medical evaluation required.
Related peptides
Other protocols in the Regeneration category that are often combined with BPC-157.
Take the Next Step
For Your Health Today
Schedule your complimentary medical evaluation and find out whether a molecular optimization program is right for you. At your pace, calm and clear.